Lemonade, Inc. (NYSE:LMND – Get Free Report) Director Michael A. Eisenberg sold 12,000 shares of the stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $40.15, for a total value of $481,800.00. Following the completion of the sale, the director now owns 94,670 shares of the company’s stock, valued at approximately $3,801,000.50. This trade represents a 11.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Lemonade Price Performance
Shares of NYSE:LMND opened at $43.74 on Tuesday. The business’s 50 day moving average price is $32.19 and its 200-day moving average price is $22.79. Lemonade, Inc. has a 1 year low of $14.03 and a 1 year high of $53.85. The firm has a market capitalization of $3.12 billion, a price-to-earnings ratio of -14.39 and a beta of 2.09.
Lemonade (NYSE:LMND – Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported ($0.95) EPS for the quarter, beating analysts’ consensus estimates of ($1.02) by $0.07. The business had revenue of $136.60 million during the quarter, compared to analysts’ expectations of $129.10 million. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The company’s quarterly revenue was up 19.3% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.88) earnings per share. On average, sell-side analysts expect that Lemonade, Inc. will post -3.04 earnings per share for the current year.
Institutional Investors Weigh In On Lemonade
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on LMND. Jefferies Financial Group reduced their target price on Lemonade from $15.00 to $14.00 and set an “underperform” rating for the company in a research note on Wednesday, October 9th. Piper Sandler upped their price target on shares of Lemonade from $25.00 to $44.00 and gave the company a “neutral” rating in a report on Thursday, November 21st. Morgan Stanley upgraded Lemonade from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $23.00 to $42.00 in a research note on Wednesday, November 20th. Keefe, Bruyette & Woods downgraded Lemonade from a “market perform” rating to an “underperform” rating and upped their target price for the stock from $18.00 to $21.00 in a research note on Thursday, November 7th. Finally, BMO Capital Markets lifted their price target on Lemonade from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Thursday, November 21st. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $30.43.
Get Our Latest Analysis on LMND
About Lemonade
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
See Also
- Five stocks we like better than Lemonade
- What Does Downgrade Mean in Investing?
- Chipotle vs. CAVA: Growth or Value—Which Stock Wins for 2025?
- Most Volatile Stocks, What Investors Need to Know
- Why Costco’s Rally May Continue Into 2025
- Short Selling: How to Short a Stock
- 3 Growth Stocks to Grab for Less Than $100
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.